Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials.
about
Corticosteroids for treating optic neuritisCorticosteroids for treating optic neuritisOral versus intravenous steroids for treatment of relapses in multiple sclerosisOral versus Intravenous Steroids for Treatment of Relapses in Multiple SclerosisCorticosteroids for the long-term treatment in multiple sclerosisCorticosteroids for treating optic neuritisEFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapsesNano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative DiseasesMethylprednisolone inhibits IFN-gamma and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitisTherapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.Optic neuritis and multiple sclerosis.Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.Emerging therapies in multiple sclerosis.Evaluating the Role of Corticosteroid Pulse Therapy in Patients With Secondary Progressive Multiple Sclerosis Receiving Mitoxantrone: A Double Blind Randomized Controlled Clinical Trial.Management of acute exacerbations in multiple sclerosis.New developments in the treatment of optic neuritis.Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis.Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study.Eye disorders in patients with multiple sclerosis: natural history and management.Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis.A predictive model for corticosteroid response in individual patients with MS relapsesRepository corticotropin injection in a patient presenting with focal segmental glomerulosclerosis, rheumatoid arthritis, and optic neuritis: a case report.Steroid treatment for relapses in multiple sclerosis - the evidence urges shared decision-making.Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.Quantification of central motor conduction deficits in multiple sclerosis patients before and after treatment of acute exacerbation by methylprednisolone.Current options for the treatment of optic neuritis.The use of cannabinoids in multiple sclerosis.Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice.Corticosteroids for multiple sclerosis: I. Application for treating exacerbations.A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms.Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosisComparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritisDiagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies.Factors that retard remyelination in multiple sclerosis with a focus on TIP30: a novel therapeutic target.Treatment of multiple sclerosis in children and adolescents.Treatment of neuromyelitis optica: an evidence based review.Management of children with multiple sclerosis.Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines.Corticosteroids in the management of acute multiple sclerosis exacerbations.
P2860
Q24187865-ADB377CA-A30E-497F-BDA7-0C11EA28F610Q24200239-389EC700-AF21-4EDB-9E9C-355F76AFF3F5Q24202564-99BC393F-D044-4502-A403-DAFF639F3F97Q24239856-37E87D4E-1364-4ABD-B241-73BAFA430989Q24242150-FA7DE471-A559-417F-8756-3C70E7EA4750Q24246536-1B583DFA-7856-4A5B-93AF-821B405AB694Q28284851-95387CEB-75AA-4729-A98C-1FE24237A016Q28546214-6E86C13B-0092-47A5-BA8B-0D82C95B159AQ28575785-976509D4-F401-4DEF-B2D3-001C4FCF1D2EQ30354658-2B4FD785-9816-4423-AAFA-51A5782AFF94Q30654054-B475CF3F-0198-4978-9AD5-09C0A1879197Q30676331-FFC9BF48-2293-4D99-A239-482F2B67A78AQ31015100-F92A8C9A-8BDC-4444-B3D2-6AC32D712E6DQ31023281-5F2D61AE-690D-4EE8-85DD-B726DBC77AD0Q33670934-839BEEDB-E308-4F1E-97FA-DAD8A3666597Q33702072-2420EF57-3890-4467-A188-B8B44B03B658Q33961774-19379428-DFEE-48B4-8D10-E493F069C05AQ34040939-AC630B4A-5A2D-4B9C-AE28-F57886FFEC49Q34399820-653ACE26-367E-4619-859C-D6C8C44A66F1Q34550413-26AC099C-9CAD-447C-84DF-837229E84BD7Q35018442-70C6F2E0-4427-4EF7-832E-A7B668700315Q35192482-2F18E31F-3094-4046-855C-152183B7DBC0Q35219562-94C8813F-6FE3-4C4F-9D27-EB2CDA414D83Q35794347-47BCF8F0-F2A6-4AB7-88C9-13201115A177Q35811145-030AEE57-2B5D-4626-85A1-FDCFC4B3FD51Q36143008-2D006465-00D5-4526-B5EB-085E53F8F9FFQ36173222-2ABE06DD-BD1D-4BBF-A0E9-C7562FB629DAQ36196473-05E1059E-C24B-48EB-92A4-680BD4314905Q36794719-D754D2EB-3CF2-4FD1-A2F7-463696071366Q36963166-B73C130B-1A81-46B2-B8C1-6E3FB5F9DBB8Q36984189-0BA0A42E-E6AC-4093-A2D0-28BAF7C9CBBDQ37052797-6B16E82B-F0C5-423D-BB95-3B14E3FBF583Q37084100-C51D8FD8-181C-46FC-97A1-B9A59012A17EQ37562166-54B479A2-3C94-46D8-BA80-6BCE0146D5E3Q37617353-6057015D-0686-4B4B-9A56-E4BA1C140A01Q37693918-A665F71B-DBB7-43EF-A068-A1236EA0BEF4Q37973248-8F07EC02-5037-4C6D-BD63-F3DEA9E918C6Q38002113-77DA1285-3460-48B9-A704-2253D9A9D17AQ38749019-3CDDD52A-ABAF-4FE3-85CB-8D24D183C271Q39229363-8CCAF042-394B-4C2E-A541-CA58AA9A61FA
P2860
Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Steroids for multiple sclerosi ...... ed controlled clinical trials.
@ast
Steroids for multiple sclerosi ...... ed controlled clinical trials.
@en
type
label
Steroids for multiple sclerosi ...... ed controlled clinical trials.
@ast
Steroids for multiple sclerosi ...... ed controlled clinical trials.
@en
prefLabel
Steroids for multiple sclerosi ...... ed controlled clinical trials.
@ast
Steroids for multiple sclerosi ...... ed controlled clinical trials.
@en
P356
P1433
P1476
Steroids for multiple sclerosi ...... ed controlled clinical trials.
@en
P2093
Brusaferri F
Candelise L
P2888
P304
P356
10.1007/S004150070172
P577
2000-06-01T00:00:00Z
P6179
1024555438